Panel of five microRNAs as potential biomarkers for the diagnosis and assessment of male infertility
Quantitative real-time polymerase chain reaction validation reveals that a set of five miRNAs deserves to be used as a diagnostic test along with other routine clinical tests, such as conventional semen and histologic analysis, to improve male infertility assessment and diagnosis.
Masood Abu-Halima, M.Sc., Mohamad Hammadeh (Prof.Dr.), Christina Backes, Ph.D., Ulrike Fischer, Ph.D., Petra Leidinger, Ph.D., Abdel Monem Lubbad, M.D., Andreas Keller (Prof.Dr.), Eckart Meese (Prof.Dr.)
Volume 102, Issue 4, Pages 989-997
To validate a set of five microRNAs (miRNAs) as specific biomarkers for the assessment of male infertility.
Quantitative real-time polymerase chain reaction (qRT-PCR) validation study.
University research and clinical institutes.
Two hundred twenty-six men presenting at an infertility clinic.
Main Outcome Measure(s):
Validation analysis of a set of miRNAs in human purified spermatozoa and testicular biopsies.
Five miRNAs (hsa-miR-34b*, hsa-miR-34b, hsa-miR-34c-5p, hsa-miR-429, and hsa-miR-122) were confirmed with the use of qRT-PCR analysis in validation sets in patients with different forms of spermatogenic impairments (subfertile and nonobstructive azoospermia [NOA]) and control subjects. We found that hsa-miR-429 was significantly increased and the four other miRNAs were decreased in both tested groups compared with normal control subjects. Computing the area under the receiver operating characteristic curve (AUC) value for each of the five miRNAs, we showed that they separated the tested groups with high accuracy (range 0.777–0.988), except for hsa-miR-429 (AUC 0.475), in patient samples with NOA. Furthermore, with the use of support vector machine classification combining these five miRNAs, we found that they discriminated individuals with, respectively, subfertility and NOA from control subjects with an accuracy of 98.65% and 99.91%, a specificity of 98.44% and 99.69%, and a sensitivity of 98.83% and 100%.
Our finding suggests that these five miRNAs have potential as novel noninvasive biomarkers to diagnose patients with subfertility. Except for hsa-miR-429, the combination of these miRNAs with other conventional tests would improve the diagnostic accuracy for detecting patients with different forms of NOA.